Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Payables (2020 - 2025)

Treace Medical Concepts' Payables history spans 6 years, with the latest figure at $8.5 million for Q4 2025.

  • For Q4 2025, Payables fell 19.49% year-over-year to $8.5 million; the TTM value through Dec 2025 reached $8.5 million, down 19.49%, while the annual FY2025 figure was $8.5 million, 19.49% down from the prior year.
  • Payables reached $8.5 million in Q4 2025 per TMCI's latest filing, down from $17.9 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $21.1 million in Q1 2024 to a low of $1.3 million in Q1 2021.
  • Average Payables over 5 years is $9.8 million, with a median of $8.6 million recorded in 2022.
  • Peak YoY movement for Payables: surged 316.65% in 2024, then plummeted 37.26% in 2025.
  • A 5-year view of Payables shows it stood at $4.1 million in 2021, then surged by 113.71% to $8.7 million in 2022, then surged by 36.54% to $11.8 million in 2023, then decreased by 11.09% to $10.5 million in 2024, then decreased by 19.49% to $8.5 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Payables are $8.5 million (Q4 2025), $17.9 million (Q3 2025), and $21.1 million (Q2 2025).